Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: Acceptability of AI-Personalized Virtual Reality Picture Books for Hospitalized Pediatric Patients Start date pushed from Oct 1, 2026 to Nov 30, 2026 Stanford UniversityNot applicable NCT07637617
  2. Notable: Walking Balance Training Post-Stroke Results posted: Nov 18, 2026 Northwestern UniversityNot applicable NCT06090604
  3. Notable: Mobile Contingency Management for Smoking Cessation Results posted: Nov 18, 2026 University of OklahomaNot applicable NCT04881630
  4. Notable: Management of Intractable Trigeminal Neuralgia of Multiple Sclerosis Patients <Bassiouni Technique> Start date pushed from Aug 31, 2026 to Nov 29, 2026 Assiut UniversityNot applicable NCT07811973
  5. Notable: Serum Electrolytes and Contrast-Induced Nephropathy in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment Primary completion date changed from estimate of May 10, 2026 to Nov 10, 2026 Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalNot specified NCT07546448
  6. Notable: Adventitial Histopathology in Borderline Ascending Aortic Dilatatio Study completion date changed from estimate of Sep 1, 2025 to Jun 30, 2026 Samsun UniversityNot specified NCT07034586
  7. Notable: Butyrate Effect on Diarrhea Primary completion date changed from estimate of Dec 31, 2025 to Oct 30, 2026 University of PadovaNot applicable NCT06982703
  8. Notable: Lokomat-Robot Assisted Gait Training on Gross Motor Function in Children and Young · Cerebral Palsy Start date pushed from Aug 31, 2026 to Jan 31, 2027 Semmelweis UniversityNot applicable NCT07732205
  9. Notable: TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention Primary completion moved earlier from Feb 17, 2040 to Oct 2036 University Medical Center NijmegenNot applicable NCT04294927
  10. Notable: Virtual Outreach and Individualized Coaching Extension Start date pushed from Oct 2026 to Dec 2026 Emory UniversityNot applicable NCT07836114
  11. Notable: Understanding How Peer Support Helps in Mental Health Care Start date pushed from Sep 2026 to Nov 2026 University of BordeauxNot specified NCT07849621
  12. Notable: Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation Start date pushed from Jan 15, 2027 to Mar 15, 2027 Johns Hopkins UniversityNot applicable NCT06989970
  13. Notable: Forging New Paths: Building Interventions · Criminogenic Needs in Community Based Mental Health Settings Results posted: Nov 18, 2026 University of North Carolina, Chapel HillNot applicable NCT06290648
  14. Notable: Nectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors Enrollment increased: 20 → 40 participants Peking University Cancer Hospital & InstituteNot applicable NCT05321316
  15. Notable: AI-enabled Communication to Advance Research Engagement (AI-CARE) Start date pushed from Oct 1, 2026 to Jan 15, 2027 Albert Einstein College of MedicineNot applicable NCT07788898
  16. Notable: MyStroke for Stroke Survivors and Caregivers Start date pushed from Nov 1, 2026 to Dec 1, 2026 University of PennsylvaniaNot applicable NCT06442631
  17. Notable: Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum Primary completion date changed from estimate of May 30, 2025 to Dec 31, 2025 University of TorontoNot specified NCT06744491
  18. Notable: Culturally Adapted Motivational Interviewing With CBT and Mindfulness Based Relapse Prevention for Substance Use Disorder in Pakistan (CAMIAB) Primary completion date changed from estimate of Jun 2025 to Jun 20, 2026 Pakistan Institute of Living and LearningNot applicable NCT04885569
  19. Minor: COVID-19 Vaccine(s) in Children and Adults Enrollment closed, study ongoing BioNTech SEPhase 3 NCT07798648
  20. Minor: Depemokimab Compared With Mepolizumab · Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial completed GlaxoSmithKlinePhase 3 NCT05263934
  21. Minor: AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) · Anemia Enrollment closed, study ongoing Kind Pharmaceuticals LLCPhase 3 NCT07494409
  22. Minor: PF-06821497 (Mevrometostat) Works · Metastatic Castration-resistant Prostate Cancer Enrollment closed, study ongoing PfizerPhase 3 NCT06629779
  23. Minor: Balcinrenone/Dapagliflozin · Heart Failure and Impaired Kidney Function Enrollment closed, study ongoing AstraZenecaPhase 3 NCT06307652
  24. Minor: Linerixibat Long-term Safety, and Tolerability Study Trial completed GlaxoSmithKlinePhase 3 NCT04167358
  25. Minor: HRS-5965 Capsule in Primary IgA Nephropathy Enrollment closed, study ongoing Chengdu Suncadia Medicine Co., Ltd.Phase 3 NCT07014826